{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:03Z","timestamp":1761518763600},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,6,24]],"date-time":"2004-06-24T00:00:00Z","timestamp":1088035200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p> <jats:bold>Abstract<\/jats:bold> <\/jats:p><jats:p><jats:bold>Background:\u2002<\/jats:bold> Angiogenesis is essential for tumour growth and metastasis. Vascular endothelial growth factor (VEGF) has been suggested as the major angio\u00adgenic factor in breast carcinoma. Both insulin\u2010like growth factor\u2010I (IGF\u2010I) and prolactin are involved in the progression of breast cancer at least partly by stimulating angiogenesis.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> The aim of the present study was to investigate the association between serum IGF\u2010I, VEGF and prolactin levels and clinicopathological characteristics of breast carcinoma.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Serum IGF\u2010I, VEGF and prolactin levels were measured in breast cancer patients and controls and these levels were compared with well\u2010known clinicopathological characteristics of breast carcinoma, including tumour size, axillary lymph node and oestrogen\/progesterone receptor status, tumour grade and disease stage.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Serum prolactin, VEGF and IGF\u2010I levels were found to be similar in breast cancer patients and control subjects (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05). When the patients were divided into groups according to their tumour size, axillary lymph node status, tumour grade, oestrogen\/progesterone receptor status and disease stage, no significant differences in serum prolactin, VEGF and IGF\u2010I levels were found among the groups (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The present study failed to demonstrate an association between serum levels of VEGF, IGF\u2010I and prolactin and well\u2010known clinicopathological characteristics of breast carcinoma. (Intern Med J 2004; 34: 310\u2212315)<\/jats:p>","DOI":"10.1111\/j.1444-0903.2004.00591.x","type":"journal-article","created":{"date-parts":[[2004,6,24]],"date-time":"2004-06-24T13:38:54Z","timestamp":1088084334000},"page":"310-315","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["No association between serum levels of insulin\u2010like growth factor\u2010I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery"],"prefix":"10.1111","volume":"34","author":[{"given":"B.","family":"Sancak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gunel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Onuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Karamercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2432664"},{"key":"e_1_2_5_3_2","first-page":"42","article-title":"Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor\u2010associated macrophages","volume":"51","author":"Polverini PJ","year":"1984","journal-title":"Lab Invest"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.655"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.2.139"},{"key":"e_1_2_5_6_2","first-page":"11","article-title":"Insulin\u2010like growth factor expression in human cancer cell lines","volume":"271","author":"Qunin KA","year":"1996","journal-title":"J Biol Chem"},{"key":"e_1_2_5_7_2","first-page":"82","article-title":"Dual effects of insulin\u2010like growth factor\u20101 on the constitutive and inducible nitric oxide (NO) synthase\u2010dependent formation of NO in vascular cells","volume":"22","author":"Schini\u2010Kerth VB","year":"1999","journal-title":"J\u2003Endocrinol Invest"},{"key":"e_1_2_5_8_2","first-page":"2867","article-title":"Angiogenic growth factors in preinvasive breast disease","volume":"5","author":"Heffelfinger SC","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1472"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900501)65:9<2028::AID-CNCR2820650924>3.0.CO;2-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910340307"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.22.10384"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-129-2-896"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","article-title":"The 16 kilodalton N\u2010terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp C","year":"1993","journal-title":"Endocrinology"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(99)00023-4"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.368"},{"key":"e_1_2_5_17_2","first-page":"374","article-title":"A specific radioimmunoassay for insulin\u2010like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF\u2010I","volume":"118","author":"Blum WF","year":"1998","journal-title":"Acta Endocrinol Copenh"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65550-2"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1876"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.356"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.9.3121"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.317"},{"key":"e_1_2_5_23_2","first-page":"821","article-title":"Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients","volume":"2","author":"Yamamato Y","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006178517505"},{"key":"e_1_2_5_25_2","first-page":"2122","article-title":"Somatomedin C receptors and growth effects in human breast cancer cells maintained in long\u2010term tissue culture","volume":"44","author":"Furnatetto RW","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_5_26_2","first-page":"4613","article-title":"Human breast cancer cells secrete an insulin like growth factor 1 related polypeptide","volume":"46","author":"Huff KK","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_5_27_2","first-page":"4083","article-title":"Differential responsiveness of human breast cancer cell lines MCF\u20107 and T47\u2010D to growth factors and 17\u2010beta estrodiol","volume":"48","author":"Karey KP","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_5_28_2","first-page":"1343","article-title":"Receptors for epidermal growth factor and insulin\u2010like growth factor I and their relation to steroid receptors in human breast cancer","volume":"48","author":"Pekonen F","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80137-6"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910520402"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/030089169408000309","article-title":"Serum levels of insulin\u2010like growth factor\u20101 in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin","volume":"80","author":"Barni S","year":"1994","journal-title":"Tumori"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620306"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01218526"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000012052"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.12.5605"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7753"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.129"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90098-8"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900501)65:9<2028::AID-CNCR2820650924>3.0.CO;2-9"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1444-0903.2004.00591.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1444-0903.2004.00591.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:23:50Z","timestamp":1696926230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1444-0903.2004.00591.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1444-0903.2004.00591.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1444-0903.2004.00591.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"2004-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}